🇺🇸 tocopherol alpha in United States

38 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Kidney Injury — 5 reports (13.16%)
  2. Blood Alkaline Phosphatase Increased — 5 reports (13.16%)
  3. Cholestasis — 5 reports (13.16%)
  4. Gamma-Glutamyltransferase Increased — 5 reports (13.16%)
  5. Hepatocellular Injury — 5 reports (13.16%)
  6. Jaundice — 5 reports (13.16%)
  7. Transaminases Increased — 5 reports (13.16%)
  8. Drug Interaction — 1 report (2.63%)
  9. Ischaemic Stroke — 1 report (2.63%)
  10. Overdose — 1 report (2.63%)

Source database →

tocopherol alpha in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is tocopherol alpha approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for tocopherol alpha in United States?

Hospices Civils de Lyon is the originator. The local marketing authorisation holder may differ — check the official source linked above.